What's important to know
Skin biological age is not a fixed value: part of the cellular and molecular changes that drive aging is modifiable.
Scientific evidence requires three levels of confirmation: mechanism → functional effect on tissue → clinical evaluation in humans.
In an independent 84-day study by Complife Italia S.r.l. (2026), the comprehensive INSTYTUTUM routine showed a reduction in the calculated skin age index by 3.0 years, a 9.0% increase in elasticity (R2), a 16.2% decrease in deformability (R0), and an 11.7% reduction in periorbital wrinkle depth (p<0.001 for all parameters).
Contents
Can the biological age of skin be reduced?
Which indicators of skin biological age can change
Proven mechanisms and marketing claims: where is the line
INSTYTUTUM results: objective data from a clinical study
Conclusions
FAQ
1. Can the biological age of skin be reduced? The scientific answer
The question of whether the biological age of skin can be reduced is no longer purely theoretical. Advances in epigenetics and the cell biology of aging have shown that aging is not an irreversible process in all of its components. The distinction between clinical improvement in appearance, functional restoration, and an actual reduction in biological age is fundamentally important to the modern concept of Longevity Skincare. Some of the changes that occur in skin cells under the influence of chronological age, ultraviolet radiation, oxidative stress, and other factors are potentially reversible.
The traditional anti-aging approach mainly evaluates what can be seen or measured on the surface of the skin. These parameters have undeniable clinical significance, but they are largely manifestations of processes that began much earlier at the cellular and molecular level. Skin aging is accompanied by gradual changes, impaired synthesis, accumulation of DNA damage, oxidative stress, epigenetic drift, and the accumulation of senescent cells. As a result, the tissue's ability to maintain a normal structural and functional state declines.
This is why the fundamental shift in the longevity approach is that the goal becomes not only reducing wrinkles that have already formed, but maintaining the cellular and tissue functions that determine how quickly skin accumulates age-related changes.
Preclinical studies using experimental models and human skin models can support hypotheses about reprogramming, aging modulation, and mitochondrial rejuvenation. Combined with assessments of epigenetic age and molecular biomarkers in vivo, these tools can improve precision in both research and clinical translation.
Skin longevity is no longer a conceptual aspiration; it is a new, biologically grounded goal that combines regenerative science with aesthetic practice. As regenerative medicine continues to advance, it is influencing not only aesthetic improvement but genuine biological rejuvenation [1].
2. Which indicators of skin biological age can change
To assess which specific biological characteristics of the skin can be targeted by a longevity approach, researchers consider not a single indicator but interconnected groups of biomarkers — ranging from the molecular to the tissue level.
1. Epigenetic regulation and methylation clocks
With age, epigenetic marks at specific DNA sites change. This affects the activity of genes responsible for skin repair and its response to damage. This is precisely why these indicators are particularly significant for Longevity Skincare.
2. Cellular senescence
Cellular senescence is a state in which cells stop dividing and fully renewing themselves. Its hallmarks include elevated levels of p16 and p21, as well as the release of pro-inflammatory molecules. The accumulation of such cells slows skin repair and contributes to the breakdown of its structural components. Because none of these markers alone is sufficiently precise, they are assessed as a group.
3. Chronic inflammation (inflammaging)
C-reactive protein (CRP) helps detect prolonged inflammation in the body and skin. It activates enzymes that break down collagen and other structural skin components. This marker therefore makes it possible to assess not only the general state of the body, but also local skin-aging processes.
4. Oxidative stress and mitochondrial imbalance
Levels of reactive oxygen species — a marker of oxidative DNA damage — indicate how effectively the skin protects itself against oxidative stress and cellular damage. Given constant exposure to UV radiation, this axis is particularly relevant for the skin.
5. Barrier function and the microbiome
Transepidermal water loss (TEWL), corneometric hydration measurements, and microbial diversity reflect not so much the skin’s "age" directly as its ability to withstand external stress — which matters for long-term care.
3. Proven mechanisms and marketing claims: where is the line
The Longevity Skincare concept has scientific value only when there is a clear distinction between the biological mechanism of action of an active ingredient, the clinically confirmed effect of the finished product, and the marketing interpretation of the result. This is especially important for claims involving "longevity," "biological age," or "rejuvenation," since such claims require a substantially stronger evidence base than simply demonstrating improvement in a single clinical parameter.
The current scientific framework for Longevity Skincare proposes evaluating such products through three sequential levels of evidence: the effect on an established aging mechanism, confirmation of a functional effect at the tissue level, and clinical evaluation in humans.
Modern approaches recommend assessing a combination of markers associated with specific hallmarks of aging: DNA damage and the response to it, epigenetic changes, cellular senescence, chronic inflammation, changes in intercellular communication, and stem cell depletion.
The next level is evidence that the molecular effect obtained has functional significance for the skin itself. Reconstructed 3D skin and ex vivo models better reproduce the structural organization of tissue and make it possible to evaluate not just an isolated cellular response, but also changes in structure, inflammation, and other functional characteristics. Such models can therefore serve as an important intermediate step between laboratory research on an active ingredient and its clinical application.
However, even a convincing mechanistic result is not proof that a product slows or reverses biological aging of human skin. This requires evaluation of additional clinical parameters, assessing both traditional endpoints — hydration, elasticity, density, pigmentation, and wrinkles — and, where possible, biomarkers directly linked to aging processes, since these more holistically reflect skin function compared with fragmented cellular-senescence markers [2, 3, 4]. These approaches are particularly important for interpreting claims related to skin-longevity care.
To assess which specific biological characteristics of the skin can change with age and potentially serve as targets for a longevity approach, it is appropriate to consider not a single universal indicator, but several interconnected groups of biomarkers. Current reviews likewise regard a multilevel assessment — from molecular and cellular markers to overall tissue characteristics — as the most appropriate approach to studying skin aging [5].
4. INSTYTUTUM results: clinical study data
Based on the need for objective, independent measurement of results, an important component of the INSTYTUTUM approach is assessing not only subjective perception of the skin, but also quantitative parameters related to its structural and functional state.
Several validated instrumental methods were used to assess skin condition:
PrimosCR SF (Canfield Scientific) — 3D analysis of the skin surface with quantitative assessment of wrinkle depth. The study analyzed wrinkle depth in the periorbital area ("crow’s feet").
Cutometer MPA 580 — assessment of the skin's mechanical properties using controlled suction. The following were analyzed:
R2 (Ua/Uf) — overall skin elasticity;
R0 (Uf) — a parameter characterizing the skin's passive deformation, used in the study as an indicator of firmness.
Visia-CR — standardized digital photography of the skin to document its visual condition.
According to an independent 84-day clinical-instrumental study conducted by Complife Italia S.r.l. in 2026, regular use of the comprehensive INSTYTUTUM routine was accompanied by statistically significant changes in a number of objective skin parameters. In particular, the calculated skin age index shifted by 3.0 years toward younger values. At the same time, the R2 (Ua/Uf) parameter, which characterizes overall skin elasticity, increased by 9.0%, while R0 (Uf), which reflects the skin's capacity for deformation and is related to its firmness, decreased by 16.2% (p<0.001 for both parameters) [6].
Changes in biomechanical parameters are significant in the context of assessing age-related skin changes. Studies using the Cutometer show that the R2 parameter, in particular, is associated with age and can be used to quantitatively characterize changes in skin elasticity. Its dynamics within this clinical study therefore complement the assessment of skin age status, since previous studies have shown that an increase in R2 is associated with a decrease in the biological age of the skin [7, 8].
Another objective result was an 11.7% reduction in average periorbital wrinkle depth after 12 weeks compared with baseline (p<0.001). Taken together, these results indicate improvement across a number of parameters related to age-related skin changes [6].
Importantly, these results are fundamentally different from generic marketing claims about "rejuvenation." In this case, the discussion is not about a visual metaphor or an assumption regarding a change in biological age, but about the dynamics of specific, instrumentally measured indicators. More details on the study: https://instytutum.com/en/biological-age-research/
Conclusions
To assess which specific biological characteristics of the skin can change with age, it is appropriate to consider not a single universal indicator, but several interconnected groups of biomarkers — ranging from molecular and cellular markers to overall tissue characteristics — as the most appropriate approach to studying skin aging.
At the same time, scientific rigor requires distinguishing between levels of evidence: molecular mechanism, functional effect at the tissue level, and clinical evaluation in humans. It is this last level — an independent clinical study with instrumental measurements — that distinguishes a substantiated claim about a reduction in the skin’s biological age from the marketing metaphor of "rejuvenation."
The 84-day study by Complife Italia S.r.l. (2026) demonstrates that the comprehensive INSTYTUTUM routine produces statistically significant changes across several independent instrumental parameters simultaneously — elasticity, firmness, and wrinkle depth — corresponding precisely to this level of evidence within the Longevity Skincare concept.
According to an independent 84-day clinical-instrumental study conducted by Complife Italia S.r.l. in 2026 using the comprehensive INSTYTUTUM routine, the calculated skin age index shifted by 3.0 years toward younger values.
Discover the world of INSTYTUTUM
Analyze the condition of your skin with INSTYTUTUM services
FAQ
Can the biological age of skin really be reduced, or is this only a cosmetic effect?
Yes — according to preclinical research, some skin-aging processes are potentially modifiable at the molecular and epigenetic level. However, this can only be stated accurately when clinical data, not just laboratory data, are available.
How does the biological age of skin differ from chronological age?
Chronological age is the number of years lived. The biological age of skin reflects the actual state of cellular and tissue function — the rate at which the skin accumulates age-related changes — and may differ from a person's chronological age.
Which indicators are used to assess the biological age of skin?
Six main groups: epigenetic changes, cellular senescence, chronic inflammation, changes in skin structure, oxidative stress and mitochondrial function, and the state of the protective barrier and microbiome.
How can a scientific claim about a longevity effect be distinguished from a marketing one?
A scientific claim relies on three levels of evidence — mechanism, functional effect at the tissue level, and clinical evaluation in humans. If a claim is based solely on a laboratory effect of an active ingredient without clinical confirmation on the finished product, it does not constitute evidence of an effect on the biological age of human skin.
What did the INSTYTUTUM clinical study show?
In an independent 84-day study by Complife Italia S.r.l. (2026), the INSTYTUTUM routine showed a reduction in the calculated skin age index of 3.0 years, a 9.0% increase in elasticity (R2), a 16.2% decrease in deformability (R0), and an 11.7% reduction in periorbital wrinkle depth (all changes statistically significant, p<0.001). More details on the study results are available at https://instytutum.com/en/biological-age-research/.
Sources
Haykal D, Gold M, Lain E, Green J, Farris PK. Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity. J Cosmet Dermatol. 2026 Mar;25(3):e70788. doi: 10.1111/jocd.70788. PMID: 41792029; PMCID: PMC12965852.
Crespi O, Rosset F, Pala V, Sarda C, Accorinti M, Quaglino P, Ribero S. Cosmeceuticals for Anti-Aging: Mechanisms, Clinical Evidence, and Regulatory Insights—A Comprehensive Review. Cosmetics. 2025; 12(5):209. https://doi.org/10.3390/cosmetics12050209
Klinngam W, Chaiwichien A, Osotprasit S, Ruktanonchai U, Kanlayavattanakul M, Lourith N, Wongrakpanich A, Teeranachaideekul V, Iempridee T. Longevity cosmeceuticals as the next frontier in cosmetic innovation: a scientific framework for substantiating product claims. Front Aging. 2025 May 22;6:1586999. doi: 10.3389/fragi.2025.1586999. PMID: 40475790; PMCID: PMC12137348
Yao, Y., Zhang, Z., Zhang, J. et al. In vitro modelling of extracellular matrix changes during skin aging: from static 2D to 3D dynamic microphysiological systems. Microsyst Nanoeng 12, 70 (2026).
Haykal D, Flament F, Suwanchinda A, Zheng Q, Rowland-Payne C, Colonna A. Predictive Biomarkers: A New Frontier in Bespoke Aesthetic Dermatology. Aesthet Surg J Open Forum. 2025 Nov 24;7:ojaf155. doi: 10.1093/asjof/ojaf155. PMID: 41394265; PMCID: PMC12696351
Complife Italia S.r.l. CLINICAL-INSTRUMENTAL EVALUATION OF THE EFFICACY OF A COSMETIC ROUTINE. INSTYTUTUM AG. Clinical study report - H.E.HU.MP.NAA00.020.01.00_IT0001183/26. Italy; 2026
Chen D, Yin S, Lu X, Fu H, Gao H, Zhang S. Research on the Correlation Between Skin Elasticity Evaluation Parameters and Age. Cosmetics. 2024; 11(6):205. https://doi.org/10.3390/cosmetics11060205
Lu WH, Guyonnet S, Raffin J, Bessou-Touya S, Helffer KR, Bianchi P, Digabel JL, Bensadoun P, Lemaitre JM, Barreto PS, Vellas B; IHU HealthAge INSPIRE/Open Science study group. Associations of Skin Biomechanical Properties With Biological Aging Clocks and Longitudinal Changes in Intrinsic Capacity in Adults Aged 20-93: The INSPIRE-T Project. Aging Cell. 2025 Oct;24(10):e70190. doi: 10.1111/acel.70190. Epub 2025 Aug 10. PMID: 40785275; PMCID: PMC12507415
